{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:27:04Z","timestamp":1787009224694,"version":"build-2736575974"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"DOI":"10.1007\/s00392-026-03013-2","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T11:08:59Z","timestamp":1786964939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prediabetes and the risk of atrial fibrillation and heart failure: a propensity-matched analysis in a real-world cohort"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5575-4208","authenticated-orcid":false,"given":"Kohei","family":"Ukita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotta","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Schmelter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland Richard","family":"Tilz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"3013_CR1","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM et al (2024) 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 45:3314\u20133414","journal-title":"Eur Heart J"},{"key":"3013_CR2","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.jacc.2017.07.755","volume":"70","author":"JB Echouffo-Tcheugui","year":"2017","unstructured":"Echouffo-Tcheugui JB, Shrader P, Thomas L, Gersh BJ, Kowey PR, Mahaffey KW et al (2017) Care patterns and outcomes in atrial fibrillation patients with and without diabetes: ORBIT-AF registry. J Am Coll Cardiol 70:1325\u20131335","journal-title":"J Am Coll Cardiol"},{"key":"3013_CR3","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jacc.2019.07.020","volume":"74","author":"A Wang","year":"2019","unstructured":"Wang A, Green JB, Halperin JL, Piccini JP Sr (2019) Atrial fibrillation and diabetes mellitus: JACC review topic of the week. J Am Coll Cardiol 74:1107\u20131115","journal-title":"J Am Coll Cardiol"},{"key":"3013_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00135","volume":"10","author":"LJ Bohne","year":"2019","unstructured":"Bohne LJ, Johnson D, Rose RA, Wilton SB, Gillis AM (2019) The association between diabetes mellitus and atrial fibrillation: clinical and mechanistic insights. Front Physiol 10:135","journal-title":"Front Physiol"},{"key":"3013_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-021-01423-2","volume":"20","author":"F Alijla","year":"2021","unstructured":"Alijla F, Buttia C, Reichlin T, Razvi S, Minder B, Wilhelm M et al (2021) Association of diabetes with atrial fibrillation types: a systematic review and meta-analysis. Cardiovasc Diabetol 20:230","journal-title":"Cardiovasc Diabetol"},{"key":"3013_CR6","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/joim.13688","volume":"294","author":"C Johansson","year":"2023","unstructured":"Johansson C, \u00d6rtendahl L, Lind MM, Andersson J, Johansson L, Brunstr\u00f6m M (2023) Diabetes, prediabetes, and atrial fibrillation-a population-based cohort study based on national and regional registers. J Intern Med 294:605\u2013615","journal-title":"J Intern Med"},{"key":"3013_CR7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jdiacomp.2018.02.004","volume":"32","author":"D Aune","year":"2018","unstructured":"Aune D, Feng T, Schlesinger S, Janszky I, Norat T, Riboli E (2018) Diabetes mellitus, blood glucose and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies. J Diabetes Complications 32:501\u2013511","journal-title":"J Diabetes Complications"},{"key":"3013_CR8","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1161\/01.CIR.0000103131.70301.4F","volume":"108","author":"RJ Aviles","year":"2003","unstructured":"Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA et al (2003) Inflammation as a risk factor for atrial fibrillation. Circulation 108:3006\u20133010","journal-title":"Circulation"},{"key":"3013_CR9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/joa3.12077","volume":"34","author":"P Korantzopoulos","year":"2018","unstructured":"Korantzopoulos P, Letsas KP, Tse G, Fragakis N, Goudis CA, Liu T (2018) Inflammation and atrial fibrillation: a comprehensive review. J Arrhythm 34:394\u2013401","journal-title":"J Arrhythm"},{"key":"3013_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.862164","volume":"13","author":"K Ihara","year":"2022","unstructured":"Ihara K, Sasano T (2022) Role of inflammation in the pathogenesis of atrial fibrillation. Front Physiol 13:862164","journal-title":"Front Physiol"},{"key":"3013_CR11","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1161\/CIRCRESAHA.121.318159","volume":"128","author":"WJ Paulus","year":"2021","unstructured":"Paulus WJ, Zile MR (2021) From systemic inflammation to myocardial fibrosis: the heart failure with preserved ejection fraction paradigm revisited. Circ Res 128:1451\u20131467","journal-title":"Circ Res"},{"key":"3013_CR12","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/j.jacc.2019.02.045","volume":"73","author":"JF Huizar","year":"2019","unstructured":"Huizar JF, Ellenbogen KA, Tan AY, Kaszala K (2019) Arrhythmia-induced cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol 73:2328\u20132344","journal-title":"J Am Coll Cardiol"},{"key":"3013_CR13","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jchf.2023.11.016","volume":"12","author":"JA Keefe","year":"2024","unstructured":"Keefe JA, Garber R, McCauley MD, Wehrens XHT (2024) Tachycardia and atrial fibrillation-related cardiomyopathies: potential mechanisms and current therapies. JACC Heart Fail 12:605\u2013615","journal-title":"JACC Heart Fail"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-026-03013-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-026-03013-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-026-03013-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:01:42Z","timestamp":1787007702000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-026-03013-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":13,"alternative-id":["3013"],"URL":"https:\/\/doi.org\/10.1007\/s00392-026-03013-2","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.R.T. has received honoraria for lectures from Pfizer, Abbott, Biosense Webster, Boston Scientific, Doctrina Med, cme4u, Medtronic, Radcliff Cardiology, and Wikonect. He has received honoraria for advisory board participation and consulting from Boston Scientific, Biosense Webster, Capvision, Guidepoint, Haemonetics, Medtronic, Philips, and Abbott. His institution has received research funding or participated in clinical trials sponsored by Biotronik, Abbott, Boston Scientific, Medtronic, Lifetech, and Johnson & Johnson. He has also received travel grants from Biosense Webster, Abbott, Boston Scientific, Medtronic, and Philips.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}